Friday, October 9, 2015: 8:30 AM-10:00 AM
Room: 31--ABC
Co-organized with IDSA Immunocompromised Host Working Group and the Immunocompromised Host Society (ICHS)
Learning Objectives:
At the conclusion of this session, participants will be able to:
- critically appraise the genetic factors predisposing to fungal infection
- discuss novel fungal diagnostic approaches
- describe new development in the management of invasive fungal disease
Target Audience: Scientists, Researchers, Pharmacists, Microbiologists, Members-in-training, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, HIV specialists, HIV clinicians, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians
Tracks: Pediatric ID, Investigative ID, HIV-STD-TB, Adult ID, Trainee
Moderators:
Thomas Patterson, MD, FIDSA, The University of Texas Health Science Center
and
Kimberly Hanson, MD, MHS, University of Utah School of Medicine
Presentations:
8:30 AM
9:30 AM
CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM
ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE
ACPE Number: 0221-9999-15-172-L01-P
Disclosures:
T. Patterson,
Astellas:
Scientific Advisor
,
Consulting fee
Merck:
Scientific Advisor
,
Consulting fee
Toyama:
Scientific Advisor
,
Consulting fee
Pfizer:
Consultant
,
Speaker honorarium
Revolution Medicines:
Consultant
,
Consulting fee
See more of: Symposium